Hitting a new 52-week high with today's 6th consecutive volume-driven gain, rallying straight up from its 200 DMA line. Reported earnings +65% on +27% sales revenues for the Sep '21 quarter, its 5th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Showing encouraging sales revenues acceleration in recent quarterly comparisons. Annual earnings history (A criteria) has been up and down.
There was a "negative reversal" and slump back below its 50 DMA line after early gains today challenging its 52-week high. Reported earnings +60% on +27% sales revenues for the Dec '14 quarter, its 3rd consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Showing encouraging sales revenues acceleration in recent quarterly comparisons.
Perched at its 52-week high following gains with above average volume, extended from any sound base. Reported earnings +63% on +13% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Recently wedged to new highs with gains lacking great volume conviction. Found recent support at its 50 DMA line and prior highs in the $26 area. Reported earnings +63% on +13% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
There was a "negative reversal" on 10/22/14 after hitting a new 52-week high. Found recent support at its 50 DMA line and prior highs in the $26 area. Reported earnings +63% on +13% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
There was a "negative reversal" on 10/22/14 after hitting another new 52-week high. Found recent support at its 50 DMA line and prior highs in the $26 area. Reported earnings +63% on +13% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Reversed into the red on the prior session after hitting another new 52-week high following 6 consecutive volume-driven gains. Found recent support at its 50 DMA line and prior highs in the $26 area. Reported earnings +63% on +13% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Reversed into the red today after hitting another new 52-week high following 6 consecutive volume-driven gains. Found recent support at its 50 DMA line and prior highs in the $26 area. Reported earnings +63% on +13% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Hitting a new 52-week high with above average volume behind today's 6th consecutive gain. Found support at its 50 DMA line and prior highs in the $26 area. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Slumping to its 50 DMA line with today's 3rd consecutive loss. Prior highs in the $26 area may act as support. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Churning above average volume while recently consolidating above prior highs in the $26 area. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Perched at its 52-week high, recently churning above average volume while remaining above prior highs in the $26 area. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Perched at its 52-week high, recently churning above average volume while remaining above prior highs in the $26 area. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Perched at its 52-week high churning above average volume while remaining above prior highs in the $26 area. Noted in prior mid-day reports with caution - "Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria)."
Touched a new 52-week high with today's 4th consecutive gain. Undercut it 50 DMA line then rebounded since last noted in the 7/23/14 mid-day report with caution. Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria).
Reported earnings +29% on +8% sales revenues for the Jun '14 quarter, but prior quarterly comparisons had earnings below the +25% minimum guideline (C criteria). Touched another new 52-week high today then reversed into the red. Rallied from a sound base on the prior session with a volume-driven gain.
Reported earnings +21% on +6% sales revenues for the Mar '14 quarter, and prior quarterly comparisons also had earnings below the +25% minimum guideline (C criteria). Perched near its 52-week high, extended from any sound base.